CRISPR-Based Diagnostic Platforms for Sensitive and Specific Detection of Nucleic Acid Targets using Split-Luciferase
This technology uses CRISPR-based systems with split-luciferase reporters and color-coded beads to rapidly and sensitively detect multiple genetic targets at once, producing luminescent signals for easy, accurate, and multiplexed molecular diagnostics.
Background
Molecular diagnostics is a rapidly evolving field that focuses on the detection and analysis of nucleic acids (DNA and RNA) to diagnose diseases, identify pathogens, and guide treatment decisions. The need for highly sensitive, specific, and rapid diagnostic tools has become especially urgent in the context of emerging infectious diseases, pandemics, and the growing demand for personalized medicine. Traditional diagnostic methods, such as PCR and immunoassays, while effective, often require complex instrumentation, skilled personnel, and lengthy processing times. As a result, there is a strong push toward developing next-generation diagnostic platforms that can deliver accurate, multiplexed results in a shorter timeframe and in a wider range of settings, including point-of-care and resource-limited environments.
Current approaches to nucleic acid detection face several significant challenges. Conventional PCR-based assays, for example, are limited in their ability to simultaneously detect multiple targets due to issues with primer cross-reactivity and the complexity of multiplex assay design. Additionally, many existing methods rely on fluorescence-based readouts, which can suffer from high background noise, limited dynamic range, and the need for specialized optical equipment. These limitations hinder the scalability and accessibility of diagnostics, especially when rapid, high-throughput, or field-deployable solutions are required. Furthermore, the sensitivity and specificity of current multiplexed assays can be compromised by signal overlap and difficulties in distinguishing between closely related targets, making it challenging to achieve reliable results in complex clinical samples.
Technology
This technology integrates split-luciferase reporter systems with color-coded bead multiplexing to create a highly sensitive and specific platform for nucleic acid detection. The core mechanism involves two luciferase subunits, HiBiT and LgBiT, which are initially separated by oligonucleotide linkers designed to be cleaved by CRISPR-Cas nucleases. When a target nucleic acid is present, CRISPR-Cas effectors recognize and cleave these linkers, enabling the luciferase subunits to reassemble and emit a luminescent signal. Simultaneously, color-coded beads—each functionalized with a unique guide RNA—allow for the parallel detection of multiple targets within a single assay, often within microfluidic droplets. This dual approach leverages the collateral cleavage activity of Cas12 or Cas13, providing real-time, multiplexed, and highly sensitive detection suitable for applications ranging from infectious disease diagnostics to genetic testing.
What differentiates this technology is its combination of modularity, multiplexing, and signal amplification. The split-luciferase system ensures minimal background noise and high sensitivity by producing a signal only upon successful target recognition, while the color-coded bead platform enables simultaneous analysis of numerous targets without cross-reactivity. This synergy allows for rapid, accurate, and scalable diagnostics using minimal sample volumes, making it adaptable for both point-of-care and high-throughput laboratory settings. The programmable nature of CRISPR guide RNAs further enhances specificity, and the integration with luminescent readouts provides a quantitative, easily interpretable output. Together, these features establish a robust diagnostic solution that surpasses conventional methods in sensitivity, specificity, and versatility.
Benefits
- High sensitivity and specificity in nucleic acid detection through CRISPR-mediated split-luciferase reconstitution
- Simultaneous multiplex detection of multiple targets using color-coded bead technology
- Rapid, real-time luminescent signal generation enabling quick diagnostic results
- Modular and adaptable system compatible with various CRISPR-Cas variants and target sequences
- Efficient use of samples by analyzing multiple targets in a single assay
- Scalable throughput suitable for both point-of-care and high-throughput laboratory settings
- Enhanced signal-to-noise ratio minimizing background and improving detection accuracy
Applications
- Multiplex infectious disease diagnostics
- Genetic variant screening panels
- Point-of-care pathogen detection
- High-throughput clinical sample testing
- Syndromic respiratory panel assays
Additional info
This diagnostic system employs CRISPR-Cas nucleases to cleave oligonucleotide linkers separating split-luciferase subunits upon target recognition, reconstituting an active enzyme for luminescent signal generation. It integrates color-coded beads, each functionalized with a specific guide RNA, enabling simultaneous, multiplexed detection of multiple distinct nucleic acid targets with enhanced sensitivity and specificity.